Eurofarma
| Company type | Sociedade Anônima |
|---|---|
| Industry | Biopharmaceuticals |
| Founded | 1972 |
| Headquarters | São Paulo, Brazil |
Area served | Worldwide |
Key people | Maurízio Billi, CEO |
| Products | Pharmaceutical drugs, vaccines |
| Revenue | R$ 5.7 billion (2020) |
Number of employees | 7,600 (2020) |
| Subsidiaries |
|
| Website | www.eurofarma.com.br |
Eurofarma (Eurofarma Laboratórios S.A.) is a Brazilian multinational corporation engaged in biopharmaceutical manufacturing and is one of the largest medicine producers in Brazil and Latin America. Founded in 1972, Eurofarma offers generic, oncology and veterinary medications. Within Brazil the company is responsible for 433 products, representing 66% of the total market.
Eurofarma has active operations in 20 countries, with factories in Brazil, Argentina, Bolivia, Chile, Colombia, Ecuador, Guatemala, Mexico, Mozambique, Paraguay, Peru, Uruguay and Venezuela.